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Objective: To assess outcomes after auxiliary nurses were trained and given resources to use active manage-
ment of the third stage of labor (AMTSL) for all women giving birth in a low-resource, low-risk, rural, public
birth center setting in northern rural Honduras. Methods: Auxiliary nurses received training on estimation
of blood loss before the preintervention phase of the study (July 2004 through April 2005) and AMTSL,
including use of intramuscular oxytocin, and estimation of blood loss prior to the intervention phase (July
2007 through June 2008). Preintervention and intervention data on use of oxytocin, blood loss postpartum,
hemorrhage rates, and management interventions were collected and compared. Results: After nurses
received training on AMTSL using intramuscular oxytocin, the use of intramuscular oxytocin during the
third stage of labor increased from 63.8% to 96.5%. Postpartum hemorrhage rates decreased from 14.8% to
5.9% (P=0.001). Use of intrapartum oxytocin, which can have adverse effects, also increased: from 6.1% to
22.7% (Pb0.001). Conclusion: Training auxiliary nurses to perform AMTSL using oxytocin in this birth center
setting was effective in reducing the rate of postpartum hemorrhage; however, increased use of intrapartum
oxytocin may be an unintended outcome of the increased accessibility of oxytocin.
© 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
Postpartum hemorrhage (PPH) is the leading cause of maternal
morbidity andmortalityworldwide and accounts for 25% of allmaternal
deaths [1]. Active management of the third stage of labor (AMTSL) is an
evidence-based strategy to reduce the incidence of uterine atony,which
is the primary cause of PPH [2]. Components of AMTSL include admin-
istration of uterotonic medications to the mother within 1 minute
after delivery, use of controlled cord traction in delivery of the placenta,
and uterine massage following placental delivery [1]. The use of AMTSL
can reduce the risk of PPH (blood loss greater than 500 mL) and severe
PPH (blood loss greater than 1000 mL) and decrease the need for blood
transfusion or additional uterotonic medications [2].
The International Federation of Gynecology and Obstetrics (FIGO)
and the International Confederation of Midwives (ICM) issued a joint
statement in 2003 and reinforced it in 2006, recommending routine
use of AMTSL in all vaginal births as the optimal standard of maternity
care in all settings [1]. However, implementation of AMTSL requires
training and resources [3]. Implementation challenges in low-resource0, Ann Arbor, MI 48109, USA.
eration of Gynecology and Obstetrics.countries include variations in curricula, conflicting policies, insufficient
training, and variable access to uterotonic agents.
Honduras currently has amaternalmortality rate of 110 per 100 000
live births [4], which represents a decrease from 186 per 100 000
during the 1990s [5]. Successful efforts to reduce maternal mortality
in Honduras have focused on increasing the number of births attended
by skilled birth attendants in hospitals and free-standing birth centers
[6]. In 2004, the Honduran Ministry of Public Health officially endorsed
the universal application of AMTSL as a standard of maternity care in
all settings as a means of continuing to reduce maternal morbidity
and mortality.
Clínica Materno-Infantíl (CMI) is a free-standing, public birth cen-
ter located in northern rural Honduras in the district of Morazán. The
clinic offers pregnancy and delivery services to low-risk women from
the surrounding area, including rural communities located as much
as 4 hours away. It is the site of previous maternal health research
[7], is staffed by auxiliary nurses, and is administratively supervised
by a professional nurse and a general medicine physician who are
normally available on-call. The auxiliary nurses attend most births
alone without other immediate help. The Honduran auxiliary nurse
curriculum is a 1-year program that includes prenatal care knowledge
and experience, but not care during childbirth. Prior to staffing at
CMI, an auxiliary nurse must observe and perform supervised birthsPublished by Elsevier Ireland Ltd. All rights reserved.
Table 1
Comparison of preintervention and intervention group demographics and selected
outcomes of care.a
Preintervention
(n=229)
Intervention
(n=339)
P value
Demographics
Age, y 23.4±6.8 23.1±6.5 0.505
Parity 2±2.5 1.5±2.1 0.016
Labor management
Intravenous fluid used during labor 9 (3.9) 77 (22.7) b0.001
Labor augmentation with oxytocin 14 (6.1) 77 (22.7) b0.001
Episiotomy performed 55 (24.0) 82 (24.2)
PPH prevention and management
Estimated blood loss, mL 355±271 247±186 0.009 b
Oxytocin administered postpartum 146 (63.8) 327 (96.5) b0.001 c
PPH estimated blood loss
(revised for 07–08), ≥500 mL
34 (14.8) 20 (5.9) 0.001 c
IV placed postpartum 20 (8.7) 35 (10.3) 0.565 c
Methergine use 2 (0.9) 0 (0)
Abbreviations: PPH, postpartum hemorrhage; IV, intravenous.
a Values are given as mean±SD and number (percentage) unless otherwise indicated.
b t test with unequal variances.
c χ2 test.
Table 2
Oxytocin administration for augmentation of labor in the intervention group.a
n=334 Estimated
blood
loss, mL
Postpartum
hemorrhage
Oxytocin administered intrapartum 72 319±250 11 (15.3)
Oxytocin NOT administered intrapartum 262 222±163 9 (3.4)
P=0.007b Pb0.001 c
a Values are given as mean±SD and number (percentage) unless otherwise indicated.
b t test unequal means.
c χ2 test.
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auxiliary nurse works with an experienced auxiliary nurse or the
professional nurse at CMI in a final process of orientation prior to
attending births independently.
The aim of the present study was to assess the impact of
implementing AMTSL in a low-resource, government-funded birth
center staffed by auxiliary nurses in rural northern Honduras.
2. Materials and methods
This project was part of a larger project examining transitions
in reproductive and maternity care for women in Morazán, Yoro,
Honduras. The study was approved by the Institutional Review
Board at the University of Michigan, officials at CMI, and the local
Ministry of Public Health in Honduras. In July 2004, the research
team trained professional nurses and auxiliary nurses on the causes
and management of PPH (e.g. fundal massage, bimanual compression).
Participants were instructed in methods to estimate blood loss for
all births that occurred at the CMI. The goal of this initial study was
to determine the rate of PPH and to begin to quantify blood loss post
delivery for women cared for by auxiliary nurses.
In the preintervention phase, the auxiliary nurses were trained to
collect all postpartum vaginal blood in a stainless steel bowl below
the delivery table. The bowl included markings that noted estimated
blood volume, which were also depicted on a poster in the birth
room. The nurses visually quantified the blood loss based on the
markings and also included the amount of lost blood present on the
birth table and in the drapes. The methods used for this process are
described in further detail elsewhere [7]. The staff completed two
repeated trainings for estimating blood loss over the course of the
study period to confirm skill development and maintenance. The
auxiliary nurses did not receive training on the specific use of AMTSL
at this time owing to constrained resources at CMI.
In June 2007, a second training session was conducted to reinforce
the lessons of the initial training and add instruction on the 3 steps
of AMTSL, including use of intramuscular oxytocin immediately
following delivery. In the intervention phase, the step of measuring
blood loss using a graduated cylinder was added. The nurse also
documented the estimated amount of additional blood not captured
in the bowl, including blood on the floor, drapes, and delivery table.
These measurements were used for a total blood loss value. During
this second phase, oxytocin was made available for every woman
giving birth at CMI. Following delivery, basic demographics, total
blood loss (measured blood loss plus estimated blood unable to be
measured), labor management practices, intravenous catheter and
fluid use during labor and postpartum, oxytocin postpartum, and PPH
rates were recorded by the auxiliary nurse who attended the birth.
A local Honduran research assistant collected the forms daily and
entered the data into an SPSS electronic spreadsheet. Any unclear
responses on the data form were clarified with the birth attendant.
Empirical data from the first and second phases were combined and
analyzed using SPSS version 15 (IBM, Armonk, NY, USA) for descrip-
tive statistics, as well as the t test and χ2 test. Pb0.05 was considered
statistically significant.
3. Results
The first phase—the preintervention time period—extended
from July 27, 2004, through April 30, 2005, and included 229
women who gave birth at CMI. The second phase—the intervention
period—extended from July 2, 2007, through June 30, 2008, and
included 339 women. Both time periods had similar patient
populations. Mean age overall was approximately 23 years in
both phases. However, parity was slightly lower in the second
time period (1.5 vs 2.0; P=0.016). There were no maternal deaths
at CMI during either study period.Labor management practices are presented in Table 1. Episiotomy
rates were stable. There was a significant marked increase in the use
of oxytocin during labor from 14 to 77 cases (6.1% vs 22.1%; Pb0.001).
Following training and implementation of AMTSL, use of oxy-
tocin immediately following birth increased (63.8% vs 96.5%
Pb0.001), estimated blood loss (EBL) decreased (355±271 mL vs
247±186 mL; P=0.009), and PPH rates decreased (14.8% vs 5.9%,
P=0.001) (Table 1).
There were 6 cases of severe PPH in the preintervention period,
accounting for 2.6% of the overall cases. The range of severe blood
loss was 1000–3000 mL. In the intervention phase there were 4 cases
of severe PPH, accounting for 1.2% of the cases where the documented
blood loss was 1250–1500 mL. There was no statistical difference
between these 2 rates of severe hemorrhage (P=0.185). Intravenous
catheter placement over the 2 time periods was unchanged (8.7% vs
10.3%, P=0.565).
Womenwho received intrapartum oxytocin, a labor augmentation
technique, had a higher mean EBL compared with women who did
not receive oxytocin intraparum (319±250 mL vs 222±163 mL;
P=0.007) (Table 2). In addition, an increased rate of PPH was
observed for women who underwent labor augmentation compared
with those who did not (15.3% vs 3.4%; Pb0.001).
In a post hoc analysis based on the unexpected finding of an
increased use of intrapartum oxytocin, there was no statistically
significant difference in the mean length of labor for primiparas and
multiparas when analyzed separately based on those who received
intrapartum oxytocin compared with those who did not (P=0.055).
Total time in labor was not correlated with having a higher EBL
(Pearson=0.038, P=0.493), and after controlling for length of
labor using regression modeling, the use of intrapartum oxytocin
was significantly correlated with a higher EBL (P=0.001).
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The results of the present study indicate that PPH can be reduced
when auxiliary nurses are instructed on the use of AMTSL in a
low-resource birth center setting. Almost all women received intra-
muscular administration of oxytocin postpartum as part of AMTSL
(96.5%). This compared favorably to the preintervention phase
when oxytocin was not used as a component of AMTSL and was inter-
mittently available. With the intervention, women experienced a re-
duction in PPH of almost 9%. This reduction in the incidence of PPH
was combined with an overall reduction in mean EBL of 108 mL for
the women giving birth at CMI. Although the clinical implications of
this reduction in blood loss overall were not assessed, other investiga-
tors have argued that a reduction in EBL provides positive benefits,
particularly in low-resource settings where high rates of anemia are
prevalent [8]. Overall, the present study indicates that auxiliary
nurses in a low-resource setting can be effectively trained in the use
of AMTSL to reduce the incidence of PPH. The introduction of this
intervention appears to produce positive results for the women who
seek childbirth care at CMI.
The use of AMTSL has been evaluated in hospital settings in
Honduras, and researchers found only a 20% use of properly-
administered uterotonics for the purpose of AMTSL in facility-based
births [3]. The results of the present study compare favorably with
the results of this investigation in promoting increased use of AMTSL
by auxiliary nurses at CMI. Despite the 2004 Honduran Ministry
of Public Health's endorsement of the use of AMTSL as the standard
of care, according to a 2006 study published by the United States
Agency for International Development (USAID) and the Prevention
of Post-Partum Hemorrhage International project, AMTSL was not
included in any of the nursing school curricula and instruction on
its use was inconsistently provided during in-service education in
facilities where maternity services were provided [3]. Thus, the need
for a standardized curriculum and approach to training is an impor-
tant step in increasing the correct and consistent use of AMTSL.
Despite the positive results of increased use of AMTSL at CMI,
there were consequences to having increased access to oxytocin in
this setting. With the rise in postpartum oxytocin use, there was
also a rise in use during the first stage of labor. This increase in use
was not correlated with increased length of labor or any other risk
factor that would medically justify its use, particularly in a low-risk
birth center where continuous fetal assessment is not possible. The
results demonstrated that with the rise in oxytocin use during the
first stage of labor, there was a significant increase in mean blood
loss for participants. This increased blood loss was combined with a
significantly increased risk for PPH. The usual management and use
of intrapartum oxytocin at CMI requires that a physician is present,
but physician involvement was not evident in the cases in the second
phase of the study. Of note, when the results of this investigation
were presented to the staff at CMI, they immediately responded and
reaffirmed that the use of oxytocin in labor was an indication for
transfer to a hospital setting and/or having a physician on site, which
supported the standard of practice.
The risk of overutilization of oxytocin during the intrapartum
phase has been identified by other investigators who evaluated the
implementation of AMTSL where oxytocin was the uterotonic agent
of choice [9,10]. However, it is unclear if the use of other uterotonic
agents would have potentially reduced or eliminated the risk associ-
ated with oxytocin. Alternative uterotonic agents such as misoprostol
may not have presented as great a risk for use during labor, but
the nurses were not familiar with these agents as labor induction
or augmentation agents. Because the nurses had experience with
oxytocin use during their hospital training, it is possible that they
were more confident in using it in the birth center, even though it
was against practice standards. The present study included a series
of educational seminars that focused on presenting the results ofthe project over time. Because of this, the implications of increased
blood loss and hemorrhage with the increased use of oxytocin in
the intrapartum period could be presented, which resulted in staff
awareness and cessation of the practice.
Implementation of AMTSL in low-resource settings like CMI has
the potential to reduce the incidence of PPH, but is not without chal-
lenges. Fundamental barriers to the use of oxytocin in AMTSL are the
limited availability of needles and syringes and staffing challenges
[11]. Levold [9] recommended ways to avoid the risk of over use of
oxytocin, including instruction on appropriate and inappropriate
use of oxytocin, evidence-based clinical guidelines, and research to
document rates of induction/augmentation. These steps were put
into place during the present investigation at CMI, yet the assumption
that current labor augmentation policies would be maintained when
access to oxytocin became routine was not realized. When new prac-
tice patterns are introduced, additional supervision has been shown
to be useful for the reduction of excess use of uterotonics [3], but
this step was not in place at CMI. Finally, the implications of the use
of intrapartum oxytocin include not only the finding of increased
incidence of PPH, but also may include reduced effectiveness of
agents used to treat PPH following intrapartum oxytocin use [12].
The present study is limited in its generalizability to other sites
and settings using other types of skilled birth attendants who may
have additional education regarding the risks and appropriate uses
of oxytocin during childbirth. The potential for bias within the
conduct of the trial was considered given the unblinded nature of
the design and documentation of EBL by the same staff member
who provided care. In the context of the low-resource setting of
CMI, the methods and equipment used for the present study were
consistent with what was available on the site and sustainable be-
yond the actual trial. In general, estimating blood loss visually usually
results in underrepresentation of the total compared with other
methods [13,14]. Thus, the preintervention phase EBLs risk being an
underrepresentation of the total EBL. The addition of the graduated
cylinder for measuring blood loss in the intervention phase should
have refined the measurements and removed the risk for bias in favor
of AMTSL.
Finally, a potential secular trend influencing the data could have
been the improved skill of the birth attendants overall in PPH
management outside of the use of AMTSL. Based on observations
by the research team and independent observations of student
midwives from the USA who were present at CMI during the study
period, there were no obvious changes in practice patterns other
than the application of increased use of oxytocin; however, observers
were only present over 12 weeks of the study period at intervals of
2–3 weeks at a time. Performing AMTSL increased staff work effort,
which could arguably be a potential risk for bias against its use.
Despite increased staff effort, during the observation phases the staff
was observed conducting EBL estimations as instructed.
In summary, auxiliary nurses at CMI in Honduras were able to
effectively implement AMTSL following training, which contributed
to reduced estimated PPH rates and reduced mean postpartum esti-
mated blood loss. However, with the increased availability of oxytocin
in the birth center, the rate of intrapartum oxytocin use also increased,
resulting in overuse that has the potential to conflict with the
improvements that can be achieved with implementation of AMTSL
alone. Continued education about the risks and appropriate use
of oxytocin, including presentations of outcome data during imple-
mentation of new practices, combined with appropriate supervisory
vigilance during the process can potentially mitigate this risk.
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